en Experimental Neurobiology

Cited by CrossRef (21)

  1. Jiajia Xu, Wei Du, Yunhe Zhao, Kahleong Lim, Li Lu, Chengwu Zhang, Lin Li. Mitochondria targeting drugs for neurodegenerative diseases—Design, mechanism and application. Acta Pharmaceutica Sinica B 2022;12:2778
    https://doi.org/10.1016/j.apsb.2022.03.001
  2. Vahid Alivirdiloo, Mobasher Hajiabbasi, Morad Kohandel Gargari, Homa Kohandel Gargari, Farhood Ghazi, Mahya Mohammadi, Fatemeh Rahimi, Ahmad Mobed, Amin mehra. Neuroprotective role of nobiletin against amyloid-β (Aβ) aggregation in Parkinson and Alzheimer disease as neurodegenerative diseases of brain. Med Chem Res 2024;33:1055
    https://doi.org/10.1007/s00044-024-03237-9
  3. D. Sujatha, P. Rupasree, S. Sunitha, K.V.S.R.G. Prasad. Natural Molecules in Neuroprotection and Neurotoxicity. 2024.
    https://doi.org/10.1016/B978-0-443-23763-8.00033-6
  4. Sehyuk Oh, Sanghun Park, Gyutae Park, Nayoung Choi, Chaeri Kim, Solhee Lee, Jungseok Choi, Ravi Pandiselvam. Citrus sunki Peel Extract, Containing Nobiletin and Tangeretin, Enhances Proliferation and Differentiation in 3T3-L1 Adipocytes. Journal of Food Biochemistry 2024;2024:1
    https://doi.org/10.1155/2024/1027972
  5. Yongkang Cheng, Sansan Feng, Chuqiao Sheng, Chunfeng Yang, Yumei Li. Nobiletin from citrus peel: a promising therapeutic agent for liver disease-pharmacological characteristics, mechanisms, and potential applications. Front. Pharmacol. 2024;15
    https://doi.org/10.3389/fphar.2024.1354809
  6. Yufei Zhou, Ting Yin, Mengsha Shi, Mengli Chen, Xiaodong Wu, Kai Wang, Iokfai Cheang, Yanxiu Li, Hongcai Shang, Haifeng Zhang, Xinli Li, Nanping Wang. Nobiletin Attenuates Pathological Cardiac Remodeling after Myocardial Infarction via Activating PPARγ and PGC1α. PPAR Research 2021;2021:1
    https://doi.org/10.1155/2021/9947656
  7. Sun Meng-zhen, Li Ju, Zhang Lan-chun, Ding Cai-feng, Yang Shu-da, Yu Hao-fei, Hu Wei-yan. Potential therapeutic use of plant flavonoids in AD and PD. Heliyon 2022;8:e11440
    https://doi.org/10.1016/j.heliyon.2022.e11440
  8. Jan O. Nehlin. . 2022.
    https://doi.org/10.1016/bs.apcsb.2023.02.020
  9. Sadaf Jahan, Uzair Ahmad Ansari, Ankur Kumar Srivastava, Sahar Aldosari, Nessrin Ghazi Alabdallat, Arif Jamal Siddiqui, Andleeb Khan, Hind Muteb Albadrani, Sana Sarkar, Bushra Khan, Mohd Adnan, Aditya Bhushan Pant. A protein–miRNA biomic analysis approach to explore neuroprotective potential of nobiletin in human neural progenitor cells (hNPCs). Front. Pharmacol. 2024;15
    https://doi.org/10.3389/fphar.2024.1343569
  10. Reihaneh Ghasemi-Tarie, Zahra Kiasalari, Marzieh Fakour, Maryam Khorasani, Sedigheh Keshtkar, Tourandokht Baluchnejadmojarad, Mehrdad Roghani. Nobiletin prevents amyloid β1-40-induced cognitive impairment via inhibition of neuroinflammation and oxidative/nitrosative stress. Metab Brain Dis 2022;37:1337
    https://doi.org/10.1007/s11011-022-00949-y
  11. Lenka Koklesova, Alena Liskova, Marek Samec, Kevin Zhai, Raghad Khalid AL-Ishaq, Ondrej Bugos, Miroslava Šudomová, Kamil Biringer, Martin Pec, Marian Adamkov, Sherif T. S. Hassan, Luciano Saso, Frank A. Giordano, Dietrich Büsselberg, Peter Kubatka, Olga Golubnitschaja. Protective Effects of Flavonoids Against Mitochondriopathies and Associated Pathologies: Focus on the Predictive Approach and Personalized Prevention. IJMS 2021;22:8649
    https://doi.org/10.3390/ijms22168649
  12. Wenao Song, Li Zhang, Xiaolin Cui, Rongrong Wang, Jingyu Ma, Yue Xu, Yan Jin, Dawei Wang, Zhiming Lu. Nobiletin alleviates cisplatin-induced ototoxicity via activating autophagy and inhibiting NRF2/GPX4-mediated ferroptosis. Sci Rep 2024;14
    https://doi.org/10.1038/s41598-024-55614-4
  13. Dan Lu, Aiping Huang, Xiaoqing Tong, Xiaoyan Zhang, Songtao Li, Xiaolong Yu. Nobiletin protects against alcohol-induced mitochondrial dysfunction and liver injury by regulating the hepatic NRF1-TFAM signaling pathway. Redox Report 2024;29
    https://doi.org/10.1080/13510002.2024.2395779
  14. Yulia N. Cajas, Karina Cañón-Beltrán, Rosane Mazzarella, Carolina Nuñez-Puente, Encina M. González, Heriberto Rodriguez-Martinez, Dimitrios Rizos, Cristina A. Martinez-Serrano. Nobiletin as a novel agent to enhance porcine in vitro embryo development and quality. Theriogenology 2024;223:36
    https://doi.org/10.1016/j.theriogenology.2024.04.011
  15. Iokfai Cheang, Shengen Liao, Qingqing Zhu, Gehui Ni, Cong Wei, Zhenhua Jia, Yiling Wu, Xinli Li. Integrating Evidence of the Traditional Chinese Medicine Collateral Disease Theory in Prevention and Treatment of Cardiovascular Continuum. Front. Pharmacol. 2022;13
    https://doi.org/10.3389/fphar.2022.867521
  16. Yueshan Pang, Juan Xiong, You Wu, Weijun Ding. A review on recent advances on nobiletin in central and peripheral nervous system diseases. Eur J Med Res 2023;28
    https://doi.org/10.1186/s40001-023-01450-7
  17. Dan-Dan Wang, Feng-Juan Gao, Xue-Jin Zhang, Fang-Yuan Hu, Ping Xu, Ji-Hong Wu. Nobiletin protects retinal ganglion cells in models of ocular hypertension in vivo and hypoxia in vitro. Laboratory Investigation 2022;102:1225
    https://doi.org/10.1038/s41374-022-00813-8
  18. Dandan Wang, Fengjuan Gao, Fangyuan Hu, Jihong Wu. Nobiletin Alleviates Astrocyte Activation and Oxidative Stress Induced by Hypoxia In Vitro. Molecules 2022;27:1962
    https://doi.org/10.3390/molecules27061962
  19. Yuan Wu, Chien-shan Cheng, Qiong Li, Jing-xian Chen, Ling-ling Lv, Jia-yue Xu, Kai-yuan Zhang, Lan Zheng, Juntra Karbwang. The Application of Citrus folium in Breast Cancer and the Mechanism of Its Main Component Nobiletin: A Systematic Review. Evidence-Based Complementary and Alternative Medicine 2021;2021:1
    https://doi.org/10.1155/2021/2847466
  20. Kamatham Pushpa Tryphena, Uppala Sai Nikhil, Poojitha Pinjala, Saurabh Srivastava, Shashi Bala Singh, Dharmendra Kumar Khatri. Mitochondrial Complex I as a Pathologic and Therapeutic Target for Parkinson’s Disease. ACS Chem. Neurosci. 2023
    https://doi.org/10.1021/acschemneuro.2c00819
  21. Priyanka Sarkar, Ashish Kumar, Partha Sarathi Behera, Kavitha Thirumurugan. . 2023.
    https://doi.org/10.1016/bs.apcsb.2023.02.013